1. Home
  2. HOTH vs EDUC Comparison

HOTH vs EDUC Comparison

Compare HOTH & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Logo Educational Development Corporation

EDUC

Educational Development Corporation

N/A

Current Price

$1.49

Market Cap

12.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
HOTH
EDUC
Founded
2017
1965
Country
United States
United States
Employees
N/A
83
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
12.6M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
HOTH
EDUC
Price
$0.65
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
395.0K
47.9K
Earning Date
05-13-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
29.69
N/A
EPS
N/A
0.63
Revenue
N/A
$34,191,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.36
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$1.01
52 Week High
$2.12
$1.84

Technical Indicators

Market Signals
Indicator
HOTH
EDUC
Relative Strength Index (RSI) 38.59 77.10
Support Level $0.49 $1.25
Resistance Level $0.80 $1.54
Average True Range (ATR) 0.04 0.08
MACD -0.00 0.00
Stochastic Oscillator 11.82 83.33

Price Performance

Historical Comparison
HOTH
EDUC

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: